Melissa Teotico Triebell

Melissa Teotico Triebell, RAC, CCRC, serves as the Executive Director of Portfolio & Programs Management at Biosplice Therapeutics since May 2017, where the focus is on developing innovative small-molecule therapeutics through alternative pre-mRNA splicing. Prior experience includes consulting roles at snapIoT and serving as Vice President of Clinical Solutions at Parallel 6, where leadership transitioned the company to a clinical-focused platform. A board director for the Laboratory Robotics Interest Group from 2004 to 2017, Melissa's regulatory expertise includes roles as a consultant for True Diagnostics and as Manager of Regulatory, Clinical Affairs & Quality Assurance at Iris Molecular Diagnostics, where traditional 510(k) clearance was achieved for an in vitro diagnostic assay. Educational background includes a BA in Animal Physiology from UC San Diego.